Page last updated: 2024-09-05

n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide and fulvestrant

n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide has been researched along with fulvestrant in 1 studies

Compound Research Comparison

Studies
(n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide)
Trials
(n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide)
Recent Studies (post-2010)
(n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide)
Studies
(fulvestrant)
Trials
(fulvestrant)
Recent Studies (post-2010) (fulvestrant)
480272,7122071,196

Protein Interaction Comparison

ProteinTaxonomyn-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide (IC50)fulvestrant (IC50)
Estrogen receptorHomo sapiens (human)0.0061
Estrogen receptorRattus norvegicus (Norway rat)0.0059
Progesterone receptorHomo sapiens (human)0.0002
Steroid hormone receptor ERR1Homo sapiens (human)0.002
Bifunctional epoxide hydrolase 2Homo sapiens (human)0.006
Estrogen receptor betaHomo sapiens (human)0.0104
Bile acid receptorHomo sapiens (human)0.79
NAD-dependent protein deacylase sirtuin-5, mitochondrialHomo sapiens (human)2.6

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Choi, KC; Go, RE; Kim, CW1

Other Studies

1 other study(ies) available for n-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide and fulvestrant

ArticleYear
Effect of fenhexamid and cyprodinil on the expression of cell cycle- and metastasis-related genes via an estrogen receptor-dependent pathway in cellular and xenografted ovarian cancer models.
    Toxicology and applied pharmacology, 2015, Nov-15, Volume: 289, Issue:1

    Topics: Amides; Animals; Cathepsin D; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclin D1; Cyclin E; Estradiol; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Oncogene Proteins; Ovarian Neoplasms; Pyrimidines; Receptors, Estrogen

2015